Helius Medical Technologies is trading at $1.50 (-7.98%) in pre-market, extending a weak run from the previous session despite a lack of company-specific news.
- The decline appears to be driven by isolated selling pressure rather than a fresh corporate announcement or fundamental catalyst.
- The stock is notably moving against the broader market trend, as U.S. futures and major indices are up more than 0.5% in a risk-on morning session.